{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:16:31Z","timestamp":1783131391218,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ijantimicag.2008.07.019","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T05:14:09Z","timestamp":1222924449000},"page":"58-64","source":"Crossref","is-referenced-by-count":13,"title":["A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics\/pharmacodynamics of the antibiotic"],"prefix":"10.1016","volume":"33","author":[{"suffix":"Jr.","given":"Thomas M.","family":"File","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott V.","family":"Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome J.","family":"Schentag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mendel E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.07.019_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1469-0691.2005.01260.x","article-title":"Nosocomial bloodstream infections caused by Streptococcus pneumoniae","volume":"11","author":"Bouza","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","article-title":"Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis","volume":"162","author":"Arancibia","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/381886","article-title":"Drug-resistant pneumococcal pneumonia: clinical relevance and related factors","volume":"38","author":"Aspa","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib4","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1378\/chest.124.6.2148","article-title":"Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital","volume":"124","author":"Goss","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/thx.2003.017756","article-title":"Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome","volume":"59","author":"Menendez","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1164\/ajrccm.154.5.8912764","article-title":"Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study","volume":"154","author":"Torres","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib9","first-page":"61","article-title":"Acute infective exacerbations of chronic bronchitis","volume":"88","author":"Ball","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib10","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. http:\/\/www.goldcopd.org [accessed 5 October 2007]."},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF03259590","article-title":"Population pharmacokinetic methods to optimise antibiotic effects","volume":"5","author":"Amsden","year":"1993","journal-title":"Drug Invest"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijantimicag.2007.04.013","article-title":"Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance\u2014a controlled study","volume":"30","author":"Schentag","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/106002809102501003","article-title":"Mathematical examination of dual individualization principles (I): relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycin","volume":"25","author":"Schentag","year":"1991","journal-title":"DICP"},{"key":"10.1016\/j.ijantimicag.2008.07.019_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"43","author":"Daneman","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908003439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908003439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T07:04:29Z","timestamp":1557817469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908003439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0924857908003439"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.07.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}